Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer
Zezhong Ye(Brigham and Women's Hospital), Benjamin H. Kann(Brigham and Women's Hospital), Antti Mäkitie(University of Helsinki), Frank Hoebers(Brigham and Women's Hospital), Kareem A. Wahid(The University of Texas MD Anderson Cancer Center), Jonathan D. Schoenfeld(Brigham and Women's Hospital), Jaakko Sahlsten(Aalto University), Anna Zapaishchykova(Dana-Farber Brigham Cancer Center), Joel Jaskari(Aalto University), Jirapat Likitlersuang(Brigham and Women's Hospital), Mohamed A. Naser(The University of Texas MD Anderson Cancer Center), Clifton D. Fuller(The University of Texas MD Anderson Cancer Center), Anurag Saraf(Dana-Farber Brigham Cancer Center), Kimmo Kaski(Aalto University), Paul J. Catalano(Computational Physics (United States)), Roy B. Tishler(Dana-Farber Cancer Institute), Danielle N. Margalit(Harvard University), Robert I. Haddad(Georgetown University), Yashwanth Ravipati(Brigham and Women's Hospital), Christian V. Guthier(Brigham and Women's Hospital), Hugo J.W.L. Aerts(Harvard University), Raymond H. Mak(Brigham and Women's Hospital), Yining Zha(Brigham and Women's Hospital)
Cited by 42
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Patients' Expectations about Effects of Chemotherapy for Advanced Cancer
|New England Journal of Medicine|2012|1.1k